Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RCMac who wrote (1313)	10/21/1998 7:21:00 AM
From: BMcV	Read Replies (1) of 10280

RCMac, a premature takeover also seems to me to be a serious threat to our investment in SEPR reaching full potential. Even a 50% premium would be only $3 billion, which is nothing to a Merck or J&J (MRK's 3Q earnings out last Friday were $1.4 billion and their market cap is around $150 billion). What might block a takeover is that SEPR has its fingers in so many pies. Who wants to become the next "drug pirate"? Not Merck, for sure. Maybe J&J. But taking over all those patents involving so many big products would be such an aggressive move I doubt anyone with a standing in the industry would risk it. The fact that SEPR's strategy is just not cricket might let us get through this vulnerable premarket stage as an independent company.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next